LifeTech Scientific Corporation has announced a strategic equity investment in Affector Medtech (Suzhou) Ltd., a high-tech company in China specializing in electrophysiology and innovative medical devices. The investment, totaling RMB150 million, will be made through LifeTech's wholly-owned subsidiary, Lifetech Scientific (Shenzhen) Co., Ltd., and will be disbursed in stages contingent upon the achievement of specific milestones, such as securing employment contracts and obtaining necessary regulatory approvals from the China National Medical Products Administration. The investment will be financed through the Group's internal resources and does not constitute a notifiable or connected transaction under Hong Kong's listing rules.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.